Cystic fibrosis (CF)

[product name] Orkambi, Kalydeco

[English common name] Ivacaftor

[Chinese common name] Ivacakato

[English name] Ivacaftor-D4

[Other names in Chinese] quinoline formamide, ivacato

[Indications] KALYDECO is classified as a cystic fibrosis transmembrane conductance regulator (CFTR) Synergist. KALYDECOSuitable for treatmentCFTRHave in the geneG551DMutation6Cystic fibrosis in patients aged one year and older (CF). If the patient's genotype is unknown, use itFDAApprovedCFMutation detection to detectG551DThe presence of a mutation.

[Usage and Dosage] The recommended KALYDECO dose for adult and child patients aged 6 years and older is 150 mg tablets per 12 hours (300 mg daily total) and fat-containing foods. Examples of suitable fat-containing foods include eggs, butter, peanut butter, cheese pizza, and the like.

[Storage] stored in20-25oC(68-77oF);Allow offset15-30oC(59-86oF)

【Tips】Part of the information on this site comes from the Internet and is only used internally by pharmacists or medical staff. It is not a substitute for doctor's face diagnosis. Please consult a professional pharmacist for specific medications. Please refer to the actual product manual or the actual product for the product content.